Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
JAAD Int
.
2022 Apr 18:7:144-145.
doi: 10.1016/j.jdin.2022.03.010.
eCollection 2022 Jun.
Authors
Christine Learned
1
,
Sara Alsukait
1
,
Sandhya Deverapalli
1
,
Erika Elliott
1
,
Katherine Moody
1
,
Jeffrey Sobell
1
,
Nellie Konnikov
2
,
Melissa Ortega
3
,
David Rosmarin
1
Affiliations
1
Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.
2
Department of Dermatology, Boston VA Medical Center, Boston, Massachusetts.
3
Department of Pharmacy, Tufts Medical Center, Boston, Massachusetts.
PMID:
35497638
PMCID:
PMC9043660
DOI:
10.1016/j.jdin.2022.03.010
No abstract available
Keywords:
adverse events; drug reactions; drug-induced psoriasis; immunodermatology; psoriasis.